Sökning: id:"swepub:oai:gup.ub.gu.se/215197" >
Telomere length and...
Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA)
-
Haver, V. G. (författare)
-
Mateo Leach, I. (författare)
-
Kjekshus, J. (författare)
-
visa fler...
-
Fox, J. C. (författare)
-
Wedel, H. (författare)
-
- Wikstrand, John, 1938 (författare)
- Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
-
de Boer, R. A. (författare)
-
Van Gilst, W. H. (författare)
-
McMurray, J. J. V. (författare)
-
van Veldhuisen, D. J. (författare)
-
van der Harst, P. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2015-02-02
- 2015
- Engelska.
-
Ingår i: European Journal of Heart Failure. - : Wiley. - 1388-9842. ; 17:3, s. 313-319
- Relaterad länk:
-
https://onlinelibrar...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- AimsLeucocyte telomere length is considered a marker of biological ageing and has been suggested to be shorter in patients with CAD and heart failure compared with healthy controls. The aim of this study was to determine whether telomere length is associated with clinical outcomes in patients with ischaemic heart failure and whether this association is superior to chronological age as defined by date of birth. Methods and resultsWe measured leucocyte telomere length in 3275 patients with chronic ischaemic systolic heart failure participating in the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA) study. The primary composite endpoint was cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, which occurred in 575 patients during follow-up. We observed a significant association of leucocyte telomere lengths with the primary endpoint (hazard ratio 1.10; 95% confidence interval 1.01-1.20; P=0.03). However, this observation was not superior to age as defined by date of birth. The neutral effect of rosuvastatin treatment on clinical outcomes was not modified by baseline telomere length. ConclusionBiological age as defined by leucocyte telomere length was associated with clinical outcomes in patients with ischaemic heart failure, but this association did not add prognostic information above age as defined by date of birth.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- Leucocyte telomere length
- Ageing
- Heart failure
- Healthy ageing
- OXIDATIVE STRESS
- ASSOCIATION
- DISEASE
- MORTALITY
- MEN
- LEUKOCYTES
- BIOLOGY
- TARGET
- SOUL
- RISK
- Cardiac & Cardiovascular Systems
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Haver, V. G.
-
Mateo Leach, I.
-
Kjekshus, J.
-
Fox, J. C.
-
Wedel, H.
-
Wikstrand, John, ...
-
visa fler...
-
de Boer, R. A.
-
Van Gilst, W. H.
-
McMurray, J. J. ...
-
van Veldhuisen, ...
-
van der Harst, P ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Göteborgs universitet